Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Nickoli

Orthopaedic Surgery Circleville, OH Medical Doctor

NPI 1831452580 CMS profile 37381

130 Morris Rd, Circleville, OH 43113

Open in the dashboard

General payments

$14,153

134 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Nickoli of Circleville, OH is reported in the CMS Open Payments database as having received $14,153 across 134 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 75th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,726 12
2024 General $4,322 40
2023 General $1,923 29
2022 General $2,727 15
2021 General $695 9
2020 General $67 4
2019 General $2,693 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Nickoli
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Michael Nickoli were reported at $1,726. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Michael Nickoli Orthopaedic Surgery median Middle half National median
2019 $2,693 $644 $140–$2,844 $163
2020 $67 $312 $75–$1,860 $114
2021 $695 $520 $117–$2,495 $132
2022 $2,727 $598 $128–$2,731 $149
2023 $1,923 $461 $128–$2,264 $160
2024 $4,322 $497 $134–$2,475 $164
2025 $1,726 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $4,710 56 payments
  2. Arthrex, Inc. $3,426 32 payments
  3. CDC Medical LLC $2,880 13 payments
  4. Zimmer Biomet Holdings, Inc. $1,049 10 payments
  5. DePuy Synthes Sales Inc. $642 7 payments
  6. Djo, LLC $429 4 payments
  7. Cosa Medical, LLC $339 4 payments
  8. Medtronic, Inc. $267 2 payments
  9. Miach Orthopaedics, Inc. $229 1 payment
  10. Pacira Pharmaceuticals Incorporated $113 1 payment
  11. Other $69 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,819 110 payments
  2. Travel and Lodging $5,307 21 payments
  3. Education $1,940 2 payments
  4. Consulting Fee $87 1 payment
Products named General payments · program years 2019–2025
  1. MAKO Knees, Hips $1,667 22 payments
  2. MAKO Knees, Hips $1,636 18 payments
  3. TRIATHLON $589 3 payments
  4. Persona $501 4 payments
  5. ROSA $501 4 payments
  6. mymobility Platform $386 3 payments
  7. NA Trauma $346 4 payments
  8. NA Orthopedics $272 3 payments
  9. PLASMABLADE(TM) $267 2 payments
  10. ICONIX $256 2 payments
  11. Other $4,366 48 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

248

Median for Orthopedic Surgery: 203

Drug cost

$1,390

Median for Orthopedic Surgery: $1,433

Branded share of claims

47.2%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 77 $450
Diclofenac Sodium Generic 41 $340
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 40 $264
Oxycodone Hcl Generic 28 $112
Cephalexin Generic 34 $109
Methylprednisolone Generic 16 $95
Tramadol Hcl Generic 12 $20

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 53 billing codes

Paid by Medicare

$51,376

Of which drugs: $3,172

Medicare patients

138

Average age 71

Services billed

948

75 women, 63 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 72%
Diabetes 38%
Depression 30%
Ischemic heart disease 25%
Chronic kidney disease 22%
Cancer 18%
COPD 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 56 332 $241

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

134 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record